Fundz

Polares Medical Raises $50 Million Series C to Advance U.S. Expansion of MRace Following Strong Clinical Results. The financing was supported by DC Global Ventures, Lumination Capital, and other investors.

PRIVATEMar 03, 2026

Amount Raised

$50 Million

Round Type

Series C

BiotechnologyHealth CareMedicalTherapeutics

Investors

New Strategic InvestorDC Global VenturesLumination Capital

Description

Polares Medical SA announced the closing of a $50 million Series C financing, led by DC Global Ventures and Lumination Partners. The funding will be used to advance U.S. clinical studies for the MRace Posterior Leaflet Replacement system. Over 70 patients have already been implanted with the system, generating positive outcomes

Quick answer

Polares Medical SA raised $50 Million in a Series C round, dated March 3, 2026. Investors: New Strategic Investor, DC Global Ventures and Lumination Capital.

How much did Polares Medical SA raise?
Polares Medical SA raised $50 Million in a Series C round on March 3, 2026.
Who invested in Polares Medical SA?
New Strategic Investor, DC Global Ventures and Lumination Capital are named as investors in this round.
What does Polares Medical SA do?
Polares Medical SA is a clinical-stage structural heart company developing the MRace Posterior Leaflet Replacement system, a novel transcatheter therapy designed to treat patients suffering from mitral regurgitation.

Source: Fundz verified event record.

Who else raised in Medical and Therapeutics around the same time

Companies in the same sectors as Polares Medical SA that raised within 45 days of this round, from Fundz verified event records.

  • TransCode Therapeutics raised $20M (Funding Round) on April 7, 2026.
  • Sonire Therapeutics raised $18M (Series A) on March 31, 2026.
  • TippingPoint Biosciences raised $4.5M (Seed) on March 31, 2026.
  • Diamyd Medical raised $125M (Funding Round) on March 23, 2026.
  • Combat Medical raised $3.5M (Series A) on March 12, 2026.
  • NexCure raised $19M (Series A) on March 5, 2026.

Who to call at Polares Medical SA, and when

A new round usually means Polares Medical SA is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Polares Medical SA raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Polares Medical SA, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Polares Medical SA. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Polares Medical SA

About

Polares Medical SA is a clinical-stage structural heart company developing the MRace Posterior Leaflet Replacement system, a novel transcatheter therapy designed to treat patients suffering from mitral regurgitation. The company is focused on expanding transcatheter treatment options and addressing one of the largest markets in structural heart. With clinical experience across a broad spectrum of mitral anatomies, Polares aims to simplify procedures and preserve future treatment pathways for patients with mitral regurgitation.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Polares Medical SA raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for Polares Medical SA's next move

See what Strategic adds

Polares Medical SA raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.